CRT 2024
Innovation
HHS
FDA Town Hall [Non-CME]
Wayne Batchelor, MD, MHS
Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States
No relationships to disclose
Mitchell Krucoff, MD, FACC
Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States
Disclosure information not submitted.
Bram Zuckerman, MD
Director Office of CV Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States
No relationships to disclose
David Erlinge, MD, PhD
Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden
No relationships to disclose
Nicole Ibrahim, PhD
Deputy Office Director, OCVD
U.S. Food and Drug Administration
Silver Spring, Maryland, United States
Disclosure(s): No financial relationships to disclose
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI
Director, The Women’s Heart and Vascular Center at Mount Sinai Heart
Director, The Center for Interventional Cardiovascular Research and Clinical Trials
Endowed Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes
Professor of Medicine (Cardiology)
Professor of Population Health Science and Policy
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States
Disclosure information not submitted.
Rebecca Torguson, MPH
Division Director
FDA
Silver Spring, Maryland, United States
No relationships to disclose
Roseann M. White, MA
Senior Director of Biostatistics
Edwards Lifesciences
Chapel Hill, North Carolina, United States
No relationships to disclose
Robert W. Yeh, MD, MSc
Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
No relationships to disclose